ES2136290T3 - Metodo para separar componentes protectores de bordetella pertussis. - Google Patents
Metodo para separar componentes protectores de bordetella pertussis.Info
- Publication number
- ES2136290T3 ES2136290T3 ES95917474T ES95917474T ES2136290T3 ES 2136290 T3 ES2136290 T3 ES 2136290T3 ES 95917474 T ES95917474 T ES 95917474T ES 95917474 T ES95917474 T ES 95917474T ES 2136290 T3 ES2136290 T3 ES 2136290T3
- Authority
- ES
- Spain
- Prior art keywords
- bordetella pertussis
- components
- pertussis
- protective
- protective components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000588832 Bordetella pertussis Species 0.000 title abstract 6
- 230000001681 protective effect Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000000746 purification Methods 0.000 abstract 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
- 201000005702 Pertussis Diseases 0.000 abstract 1
- 229910001424 calcium ion Inorganic materials 0.000 abstract 1
- 229910000389 calcium phosphate Inorganic materials 0.000 abstract 1
- 239000001506 calcium phosphate Substances 0.000 abstract 1
- 235000011010 calcium phosphates Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
PARA PROPORCIONAR UN METODO EFICIENTE DE SEPARACION DE COMPONENTES PROTECTORES DE BORDETELLA PERTUSSIS. EN BASE A LAS DIFERENCIAS DE ADSORBABILIDAD DEL GEL DE FOSFATO CALCICO FORMADO POR ADICION DE IONES CALCIO AL CULTIVO DE BORDETELLA PERTUSSIS EN PRESENCIA DE EXCESO DE IONES DE FOSFATO, LOS COMPONENTES PROTECTORES DE LA BORDETELLA PERTUSSIS SON SEPARADOS DEL CULTIVO DE BORDETELLA PERTUSSIS. TRADICIONALMENTE, LOS COMPUESTOS PROTECTORES DE LA BORDETELLA PERTUSSIS HAN SIDO SEPARADOS USANDO METODOS DE PURIFICACION DIFERENTES PARA LOS RESPECTIVOS COMPONENTES. DE ACUERDO CON LA PRESENTE INVENCION, EL USO DE LOS MISMOS MEDIOS DE PURIFICACION PARA TODOS LOS COMPONENTES HACE POSIBLE PURIFICAR CADA COMPONENTE CON ALTA EFICIENCIA Y UNA ALTA VELOCIDAD DE RECUPERACION, UN ASPECTO MUY VENTAJOSO PARA LA PRODUCCION INDUSTRIAL. TAMBIEN ES POSIBLE PRODUCIR EFICIENTEMENTE UNA VACUNA MEJORADA DE COMPONENTES DE PERTUSSIS PURIFICADOS QUE COMPRENDE UNA COMBINACION EFECTIVA DE HEMAGLUTININA FILAMENTOSA PERTUSSIS(FAH), PERTACTINA (PRN, 69K-OMP), PERTUSSIS FIMBRIOSA (FIM) Y TOXINA PERTUSSIS (PT)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9156594 | 1994-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2136290T3 true ES2136290T3 (es) | 1999-11-16 |
Family
ID=14030044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95917474T Expired - Lifetime ES2136290T3 (es) | 1994-04-28 | 1995-04-26 | Metodo para separar componentes protectores de bordetella pertussis. |
Country Status (12)
Country | Link |
---|---|
US (6) | US6051240A (es) |
EP (1) | EP0755403B1 (es) |
KR (1) | KR100266556B1 (es) |
CN (1) | CN1147259A (es) |
AT (1) | ATE183194T1 (es) |
AU (1) | AU2352595A (es) |
CA (1) | CA2188424A1 (es) |
DE (1) | DE69511392T2 (es) |
DK (1) | DK0755403T3 (es) |
ES (1) | ES2136290T3 (es) |
GR (1) | GR3031481T3 (es) |
WO (1) | WO1995029934A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8910570D0 (en) | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
US6444211B2 (en) * | 1991-04-03 | 2002-09-03 | Connaught Laboratories, Inc. | Purification of a pertussis outer membrane protein |
EP1234579A1 (en) * | 1995-05-04 | 2002-08-28 | Aventis Pasteur Limited | Acellular Pertussis Vaccines and Methods of Preparation Thereof |
WO2010131111A1 (en) | 2009-05-11 | 2010-11-18 | Novartis Ag | Antigen purification process for pertactin antigen |
US8647640B2 (en) * | 2009-06-24 | 2014-02-11 | Richard E. COWART | Vaccine compositions and methods of use to protect against infectious disease |
CN102443572B (zh) * | 2011-10-21 | 2012-12-19 | 武汉生物制品研究所有限责任公司 | 一种对脱毒后的百日咳疫苗抗原溶液进行纯化的方法 |
WO2016154010A1 (en) * | 2015-03-20 | 2016-09-29 | Makidon Paul | Immunogenic compositions for use in vaccination against bordetella |
CN109069535B (zh) * | 2016-03-29 | 2022-03-18 | 里尔巴斯德研究所 | 突变型博德特氏菌属菌株及其使用方法 |
CN108570098B (zh) * | 2017-12-29 | 2021-09-07 | 武汉生物制品研究所有限责任公司 | 一种百日咳多种抗原成分的分离纯化方法 |
CN110358802B (zh) * | 2019-08-16 | 2021-06-18 | 长春百克生物科技股份公司 | 一种去除百日咳组分菌毛蛋白2/3内毒素的方法 |
WO2022114921A1 (ko) * | 2020-11-30 | 2022-06-02 | 주식회사 엘지화학 | 알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5750925A (en) * | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
US4729957A (en) * | 1984-12-13 | 1988-03-08 | The United States Of America As Represented By The Department Of Health And Human Services | Process for manufacture of L-asparaginase from erwinia chrysanthemi |
GB8512972D0 (en) * | 1985-05-22 | 1985-06-26 | Univ Glasgow | Vaccine production |
GB8601279D0 (en) * | 1986-01-20 | 1986-02-26 | Public Health Lab Service | Purification of pertussis antigens |
CA1337859C (en) * | 1987-04-24 | 1996-01-02 | Masashi Chazono | Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine |
US5101019A (en) * | 1987-05-22 | 1992-03-31 | Takeda Chemical Industries, Ltd. | Method for removing pertussis endotoxin, a pertussis toxoid and its production |
GB8807860D0 (en) * | 1988-04-05 | 1988-05-05 | Connaught Lab | Pertussis vaccine |
US5101014A (en) * | 1989-02-10 | 1992-03-31 | United States Of America | Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis |
DE69025375T2 (de) * | 1989-11-06 | 1996-08-01 | Smithkline Beecham Biolog | Verfahren |
US5276142A (en) * | 1989-12-11 | 1994-01-04 | American Cyanamid Company | Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis |
GB9007657D0 (en) * | 1990-04-04 | 1990-05-30 | Connaught Lab | Purification of a pertussis outer membrane protein(omp69) |
IT1248735B (it) * | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
CA2123222C (en) * | 1991-11-15 | 2001-02-27 | Donald A. Dearwester | Gram-negative bacterial vaccines |
US6696065B1 (en) * | 1995-05-04 | 2004-02-24 | Aventis Pastuer Limited | Acellular pertussis vaccines and methods of preparation thereof |
EP1234579A1 (en) * | 1995-05-04 | 2002-08-28 | Aventis Pasteur Limited | Acellular Pertussis Vaccines and Methods of Preparation Thereof |
-
1995
- 1995-04-26 WO PCT/JP1995/000830 patent/WO1995029934A1/en active IP Right Grant
- 1995-04-26 KR KR1019960706030A patent/KR100266556B1/ko not_active IP Right Cessation
- 1995-04-26 CN CN95192782A patent/CN1147259A/zh active Pending
- 1995-04-26 CA CA002188424A patent/CA2188424A1/en not_active Abandoned
- 1995-04-26 US US08/530,373 patent/US6051240A/en not_active Expired - Lifetime
- 1995-04-26 DE DE69511392T patent/DE69511392T2/de not_active Expired - Fee Related
- 1995-04-26 AT AT95917474T patent/ATE183194T1/de active
- 1995-04-26 EP EP95917474A patent/EP0755403B1/en not_active Expired - Lifetime
- 1995-04-26 AU AU23525/95A patent/AU2352595A/en not_active Abandoned
- 1995-04-26 DK DK95917474T patent/DK0755403T3/da active
- 1995-04-26 ES ES95917474T patent/ES2136290T3/es not_active Expired - Lifetime
-
1999
- 1999-07-08 US US09/349,712 patent/US20020119161A1/en not_active Abandoned
- 1999-10-08 GR GR990402573T patent/GR3031481T3/el unknown
-
2002
- 2002-07-30 US US10/206,989 patent/US20030133941A1/en not_active Abandoned
-
2005
- 2005-04-14 US US11/105,540 patent/US20050180987A1/en not_active Abandoned
-
2007
- 2007-10-24 US US11/877,789 patent/US20090068228A1/en not_active Abandoned
-
2009
- 2009-08-27 US US12/461,925 patent/US20100055134A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69511392T2 (de) | 2000-03-23 |
US20030133941A1 (en) | 2003-07-17 |
GR3031481T3 (en) | 2000-01-31 |
EP0755403A1 (en) | 1997-01-29 |
CN1147259A (zh) | 1997-04-09 |
DK0755403T3 (da) | 2000-02-14 |
US20020119161A1 (en) | 2002-08-29 |
US6051240A (en) | 2000-04-18 |
EP0755403B1 (en) | 1999-08-11 |
KR100266556B1 (ko) | 2000-09-15 |
CA2188424A1 (en) | 1995-11-09 |
US20100055134A1 (en) | 2010-03-04 |
WO1995029934A1 (en) | 1995-11-09 |
US20090068228A1 (en) | 2009-03-12 |
DE69511392D1 (de) | 1999-09-16 |
KR970702874A (ko) | 1997-06-10 |
AU2352595A (en) | 1995-11-29 |
US20050180987A1 (en) | 2005-08-18 |
ATE183194T1 (de) | 1999-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2136290T3 (es) | Metodo para separar componentes protectores de bordetella pertussis. | |
ES2165115T3 (es) | Un procedimiento para la purificacion de fosfatidinilserina. | |
GT199900166A (es) | Compuesto quìmico adecuado para usar como agente antiviral.- | |
PT95099A (pt) | Processo para a preparacao de amino acidos ciclicos bem como dos seus intermediarios | |
ES2113347T3 (es) | Procedimiento para la desactivacion de virus en sangre y en productos de sangre. | |
NZ306009A (en) | Medical database system, unique identifier assigned to files, machine readable version of identifier included in hard copies | |
ATE156187T1 (de) | Verfahren zum reinigen von hepatits-a-virus (hav), so gereinigter virus und impfstoffzusammensetzungen, die ihn enthalten | |
BR0011033A (pt) | Métodos de purificação de dna e dna purificado | |
ATE92335T1 (de) | Reinigung von keuchhustenantigenen. | |
ES2140652T3 (es) | Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b. | |
ES2141093T3 (es) | Herpesvirus equinos (ehv) que contienen adn ajeno, procedimiento para su obtencion y su empleo en vacunas. | |
ES2180147T3 (es) | Procedimiento para determinar datos para el tratamiento de la cornea de un ojo. | |
ES2182827T3 (es) | Gen del virus corona canino y usos del mismo. | |
ES2125938T3 (es) | Procedimiento para la reactivacion de proteinas membranales purificadas. | |
ES2196157T3 (es) | Oligonucleotidos especificos para el virus de la hepatitis c. | |
DE69001309D1 (de) | Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist. | |
ATE395428T1 (de) | Verfahren zur isolierung und reinigung von lipidezellwandkomponenten | |
TH20014A (th) | วิธีการแยกส่วนประกอบป้องกันโรคไอกรนของ Bordetella pertussis | |
BR9712910A (pt) | ra o tratamento de infecção por hiv | |
ATE241644T1 (de) | Verfahren zur reinigung von tamm-horsfall- glykoprotein und uromodulin | |
FR2622890B1 (fr) | Procede de preparation de synthons peptidiques | |
BR9810792A (pt) | Processo para purificar óxido de propileno por destilação, uso de um óxido de propileno, polìmero produzido usando óxido de propileno purificado, e, poliuretano | |
BR9608074A (pt) | Processo para a produção e purificação de esteres cìclicos | |
KR960040378A (ko) | 신증후출혈열 백신 및 그의 제조 방법 | |
AR246984A1 (es) | Metodo para obtener monosialogangliosido (gm1) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 755403 Country of ref document: ES |